Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary. Issue 5 (8th August 2021)

Record Type:: Journal Article
Title:: Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary. Issue 5 (8th August 2021)
Main Title:: Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary
Authors:: Farrell, Sheila
Karp, Jacqueline
Hager, Rebecca
Wang, Yan
Adeniyi, Oluseyi
Wang, Jie
Li, Liang
Ma, Lian
Peretz, Jackye
Summan, Mukesh
Kong, Nicolas
White, Michael
Pacanowski, Michael
Price, Dionne
Filie, Jane
Donohue, Kathleen
Joffe, Hylton
Abstract:
Is Part Of:: Journal of inherited metabolic disease. Volume 44:Issue 5(2021)
Journal:: Journal of inherited metabolic disease
Issue:: Volume 44:Issue 5(2021)
Issue Display:: Volume 44, Issue 5 (2021)
Year:: 2021
Volume:: 44
Issue:: 5
Issue Sort Value:: 2021-0044-0005-0000
Page Start:: 1085
Page End:: 1087
Publication Date:: 2021-08-08
Subjects:: Metabolism, Inborn errors of -- Periodicals
Metabolism -- Disorders -- Periodicals
616.39042
Journal URLs:: http://www.springer.com/gb/ ↗
DOI:: 10.1002/jimd.12421 ↗
Languages:: English
ISSNs:: 0141-8955
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5006.950000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 18914.xml